A CD4 ⍣ T cell subpopulation defined by the expression levels of a particular cell surface molecule (e.g. CD5, CD45RB, CD25, CD62L or CD38) bears an autoimmune-preventive activity in various animal models. Here we show that the expression of CD25 is highly specific, when compared with other molecules, in delineating the autoimmune-preventive immunoregulatory CD4 ⍣ T cell population. Furthermore, although CD25 is an activation marker for T cells, the following findings indicate that immunoregulatory CD25 ⍣ CD4 ⍣ T cells are functionally distinct from activated or anergy-induced T cells derived from CD25 -CD4 ⍣ T cells. First, the former are autoimmunepreventive in vivo, naturally unresponsive (anergic) to TCR stimulation in vitro and, upon TCR stimulation, able to suppress the activation/proliferation of other T cells, whereas the latter scarcely exhibit the in vivo autoimmune-preventive activity or the in vitro suppressive activity. Second, such activated or anergy-induced CD25 -spleen cells produce various autoimmune diseases when transferred to syngeneic athymic nude mice, whereas similarly treated normal spleen cells, which include CD25 ⍣ CD4 ⍣ T cells, do not. Third, upon polyclonal T cell stimulation, CD25 ⍣ CD4 ⍣ T cells express CD25 at higher levels and more persistently than CD25 -CD4 ⍣ T cell-derived activated T cells; moreover, when the stimulation is ceased, the former revert to the original levels of CD25 expression, whereas the latter lose the expression. These results collectively indicate that naturally anergic and suppressive CD25 ⍣ CD4 ⍣ T cells present in normal naive mice are functionally and phenotypically stable, distinct from other T cells, and play a key role in maintaining immunologic self-tolerance.
Introduction
There is accumulating evidence that, besides clonal deletion autoimmune diseases including thyroiditis, gastritis and IDDM can be de novo produced in normal rodents by simply or anergy, T cell-mediated dominant control of self-reactive lymphocytes also contributes to the maintenance of immunoremoving a CD5 high , CD45RB low or CD25 ϩ subpopulation of CD4 ϩ T cells without exogenous immunization with selflogic self-tolerance (1-3). For example, development of T cellmediated autoimmune diseases [such as thyroiditis, gastritis antigens, and reconstitution of the removed cell population prevented the development of these autoimmune diseases and insulin-dependent diabetes mellitus (IDDM)] can be prevented in various animal models by inoculating CD4 ϩ (4) (5) (6) (7) (8) (9) (10) (11) . It remains obscure, however, whether such an immunoregulatory CD4 ϩ T cell population is functionally and pheno-T cells or a subpopulation of CD4 ϩ T cells (such as CD5 high , CD45RB low , CD62L high or CD25 ϩ CD4 ϩ T cells) prepared from typically a single entity of regulatory T cells irrespective of various cell surface phenotypes reported to date for the histocompatible normal animals (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Furthermore, various population(s); whether they are functionally distinct from other (Corning, Corning, NY) with 100 µl of 1:10-diluted ascites of immunoregulatory T cells, such as anergy-induced suppressanti-CD25 antibody (7D4, rat IgM) (30) or anti-CD8 antibody ive T cells or regulatory T cells secreting a particular immuno-(3.155) (rat IgM) for 45 min on ice, washed once with HBSS regulatory cytokine (18) (19) (20) (21) (22) (23) (24) ; and whether they are functionally (Gibco/BRL, Gaithersburg, MD), incubated with 1.0 ml of nonand phenotypically stable in the normal immune system if toxic rabbit serum [as complement (C) source] (Cederlane, they are engaged in the maintenance of immunologic selfHornby, Ontario, Canada) 1:5-diluted with Medium 199 tolerance at all.
(Gibco) for 30 min in a 37°C water bath with occasional We have previously shown that CD25 ϩ T cells, which vigorous shakings, with 100 µg of DNase I (Sigma, St. Louis, constitute 5-10% of CD4 ϩ T cells and Ͻ1% of CD8 ϩ T cells MO) added for the last 5 min of the incubation, washed twice in the periphery of normal naive mice, are able to prevent with HBSS, and then i.v. injected into 6-to 8-week-old female autoimmune disease in vivo and suppress immune responses nude mice (9) . To eliminate CD8 ϩ cells or CD4 ϩ cells, cell to non-self antigens in general (9) (10) (11) . Interestingly, the suspensions (5ϫ10 7 ) were treated with anti-CD4 antibody CD25 ϩ CD4 ϩ T cells are naturally unresponsive (anergic) to (RL172.4) or anti-CD8 antibody (3.155) as previously TCR stimulation in vitro (25) (26) (27) , if one defines anergy as a described (9) . reversible anti-proliferative state (25) . Furthermore, upon TCR stimulation, they potently suppress the activation/proliferation Serological analysis of other CD4 ϩ T cells and CD8 ϩ T cells presumably through For flow cytometric analysis, 1ϫ10 6 cells were incubated with inhibiting IL-2 formation (25) (26) (27) . This in vitro CD25 ϩ CD4 ϩ FITC-labeled or biotinylated mAb, with phycoerythrin (PE)-T cell-mediated suppression depends on cell-cell interactions streptavidin (BioMeda, Foster City, CA) as the secondary on antigen-presenting cells (APC) and does not appear to be reagent for biotinylated antibody and analyzed by a flow mediated by far-reaching or long-lasting humoral factors or cytometer (Epics-XL; Coulter, Miami, FL) with exclusion of apoptosis-inducing signals (25, 27) . Similar findings were dead cells by propidium iodide staining. FITC-labeled or also made with CD38 ϩ CD45RB low CD4 ϩ T cells (28) . Furtherbiotinylated anti-CD25 antibody (7D4), and biotinylated antimore, the normal thymus is continuously producing body for CD4 (H129.19), CD8 (53-6.7), CD45RB (16A) (31), CD25 ϩ CD4 ϩ T cells as a functionally mature immunoregula-CD62L (L-selectin) (Mel-14) (32), CD90.2 (Thy-1.2) (30-H12) tory T cell subpopulation (26) . and CD90.1 (Thy-1.1) were purchased from PharMingen (San In this report, we have attempted to further characterize Diego, CA). Biotinylated anti-CD38 antibody was a gift from the immunoregulatory CD4 ϩ T cells concerned with the mainDr K. Miyake (Saga Medical School, Saga, Japan) (33). tenance of immunologic self-tolerance. We show that, compared with other markers (such as CD45RB, CD62L or Cell sorting CD38), the expression of CD25 is highly specific for this Spleen and lymph node cell suspensions or thymocyte susimmunoregulatory T cell population and that other T cells can pensions prepared from 8-week-old BALB/c mice were hardly acquire the in vivo autoimmune-preventive activity or stained with FITC-conjugated anti-CD25 antibody (7D4) and the in vitro anergic/suppressive property when activated to a CD25 ϩ state or experimentally rendered anergic in vitro.
PE-conjugated anti-CD4 antibody (H129. 19) , and sorted by Moreover, the expression of CD25 is highly stable on these a FACS (Epics Elite; Coulter), as previously described (25) . CD4 ϩ regulatory T cells, in contrast to transient CD25 expresPurity of the CD25 ϩ and CD25 -CD4 ϩ populations was Ͼ90 sion on activated T cells in general. Our results indicate that and~99% respectively. In some experiments, CD4 ϩ T cells the CD25 ϩ CD4 ϩ T cell population present in normal naive were first enriched from spleen and lymph node cells by mice is a functionally and phenotypically unique immunoremoving B cells, CD8 ϩ T cells and adherent cells by panning regulatory population, which plays a key role in maintaining on antibody-coated plastic dishes, as previously described immunologic self-tolerance and controlling immune responses (9) , and then stained with FITC-anti-CD25 antibody along with in general.
biotinylated anti-CD62L, anti-CD45RB or anti-CD38 antibody with PE-streptavidin as the secondary reagent. CD25 ϩ CD4 ϩ T cells thus enriched were sorted into a CD62L high or Methods CD62L low , CD45RB high or CD45RB low , or CD38 high or Mice CD45RB low population (25) . Both 8-week-old BALB/c or and 6-week-old BALB/c athymic nude (nu/nu) mice were purchased from SLC (Shizuoka, Cell culture Japan). To obtain BALB/c nu/ϩ or ϩ/ϩ mice, BALB/c nu/ϩ Lymph node and spleen cells (2.0-2.5ϫ10 4 ), sorted as mice were mated in our animal facility. BALB/c-Thy-1 a condescribed above, and red blood cell-lysed, X-irradiated genic mice were established in our laboratory as previously (20 Gy)-treated BALB/c spleen cells (5ϫ10 4 ) as APC were described (10). DO11.10 transgenic mice expressing ovalcultured for 3 days in 96-well round-bottom plates (Costar) bumin (OVA)-specific transgenic TCR were the kind gift of Dr in RPMI 1640 medium supplemented with 10% FCS D. Y. Loh (Hoffman-La Roche (29) . All these mice were (Gibco/BRL), penicillin (100 U/ml) (Gibco/BRL), streptomycin maintained in our animal facility and cared for in accordance (100 µg/ml) (Gibco/BRL) and 50 µM 2-mercaptoethanol with the institutional guidelines for animal welfare.
(Sigma) (25, 26 Since CD25 is generally expressed on activated T cells (30, 37) , we examined the intensity and the pattern of CD25 To render normal spleen cells anergic in vitro, BALB/c spleen cells were cultured with 1 µM ionomycin (IM; Sigma) expression on CD25 ϩ cell-depleted or non-depleted splenic CD4 ϩ T cells prepared from normal naive BALB/c mice when overnight, as described by Jenkins et al. (35) .
the cells were stimulated with Con A (Fig. 2A) . Staining of stimulated (day 3 or 7) or pre-stimulated (day 0) spleen cells Histology and serology with FITC-anti-CD4 antibody and PE-anti-CD25 antibody Stomachs and other organs were fixed with 10% formalin and showed that the CD25 ϩ CD4 ϩ T cells present before stimulaprocessed for hematoxylin & eosin staining. Serum titers of tion increased their CD25 expression levels by day 3 and autoantibodies specific for the gastric parietal cells were retained higher CD25 expression levels than the CD25 -CD4 ϩ assayed by ELISA (36) . Gastritis was graded 0 to 2ϩ T cell-derived Con A blasts (or CD8 ϩ Con A blasts) even on depending on macroscopic and histological severity: 0, the day 7 when the CD25 expression levels on the CD25 -CD4 ϩ gastric mucosa was histologically intact; 1ϩ, gastritis with T cell-derived cells had already declined from the maximum histologically evident destruction of parietal cells and chief levels (as judged from their mean fluorescence intensity). cells with cellular infiltration of the gastric mucosa; 2ϩ, severe Furthermore, with a decline of the stimulation, the CD25 destruction of the gastric mucosa accompanying the formation expression levels on the CD25 ϩ CD4 ϩ T cell-derived blasts of giant rugae due to compensatory hyperplasia of mucousreverted to the pre-stimulation levels, whereas the CD25 -secreting cells (4, 9) .
CD4 ϩ T cell-derived blasts virtually lost CD25 expression. This difference in the time course and the intensity of CD25 expression was confirmed by preparing CD25 ϩ CD4 ϩ T cells Results or CD25 -CD4 ϩ T cells from Thy-1-congenic strains of mice ( Fig. 2B ), i.e. CD25 ϩ CD4 ϩ T cells prepared from BALB/cCell surface phenotype of naturally anergic and suppressive Thy-1 a congenic mice (which express CD90.1) and CD25 -CD25 ϩ CD4 ϩ T cells in normal naive mice CD4 ϩ T cells from BALB/c mice (which express CD90.2) were mixed at 1:9 ratio as in normal mice [in which~10% of CD4 ϩ We have previously shown that CD25 ϩ CD4 ϩ T cells present in normal naive mice contained cells expressing various levels T cells are CD25 ϩ (Fig. 1A )] and stimulated with Con A (Fig.  2B) . Indeed, the stimulated CD25 ϩ CD4 ϩ (CD90.1 ϩ ) T cells of CD45RB or CD62L, although the expression levels of these molecules might change depending on the environment under showed higher levels of CD25 expression during the stimulation than the CD25 -CD4 ϩ (CD90.2 ϩ ) T cell-derived blasts. which the mice were maintained (26) . Others have also shown that autoimmune-preventive CD4 ϩ T cells can be Thus, CD25 ϩ CD4 ϩ T cells present in normal naive mice are distinct from CD25 -T cell-derived activated T cells in intensity, CD38 ϩ CD45RB low (28) . To determine then whether the anergic property or the suppressive activity, or both, of the stability and pattern of CD25 expression when stimulated. CD25 ϩ CD4 ϩ population in normal naive mice can be attribCon A-activated T cells from normal CD4 ϩ T cells can prevent uted to a subpopulation included in it, the CD25 ϩ CD4 ϩ autoimmune disease but those from TCR transgenic mice or population was further dissected into smaller populations by activated CD8 ϩ T cells cannot expression levels of CD45RB, CD62L or CD38 and each population was assessed in vitro for proliferative response to CD4 ϩ T cells, especially CD25 ϩ CD4 ϩ T cells, in normal naive mice bear the autoimmune-preventive activity (9-11). Con A stimulation or for suppressive activity on the activation/ proliferation of co-cultured CD25 -CD4 ϩ T cells. Figure 1 To determine whether Con A-activated CD4 ϩ T cells, the majority of which express CD25 as shown in Fig. 2 , can shows that, when the CD25 ϩ CD4 ϩ T cell population was dissected to a CD45RB high or CD45RB low (Fig. 1B) , CD62L high prevent autoimmune disease as well, we transferred to BALB/c athymic nude mice the cell mixtures containing a or CD62L low (Fig. 1C ), or CD38 high or CD38 low subpopulation (Fig. 1D ) by cell sorting, every subpopulation was virtually fixed number of CD25 -cells and graded numbers of CD4 ϩ T cell blasts prepared by Con A treatment of normal BALB/c non-proliferative to the stimulation and potently suppressed the proliferation of co-cultured CD25 -CD4 ϩ T cells. The result spleen cells. The mice were examined 3 months later for the incidence of histologically evident autoimmune disease in indicates that the anergic and suppressive property of the CD25 ϩ CD4 ϩ T cell population cannot be reduced to a smaller various organs (Table 1) , for the histological severity of gastritis and for the titers of anti-parietal cell autoantibody (Fig. 3) . subpopulation defined by an expression level of CD45RB, CD62L or CD38. Furthermore, high proliferative responses of Con A blasts from CD4 ϩ T cells were able to prevent the development of autoimmune diseases in a dose-dependent CD25 -CD4 ϩ T cells (Fig. 1A) imply that CD38 high or CD38 low , CD62L high or CD62L low , or CD45RB high or CD45RB low cells fashion, but an equivalent dose of Con A blasts from CD8 ϩ T cells did not, although the preventive activity of the CD4 ϩ included in the CD25 -CD4 ϩ T cell population (Fig. 1B-D) may not be sufficiently suppressive, if at all, even if such a blasts was slightly lower when compared with the same number of unstimulated CD4 ϩ splenic T cells. By contrast, Con subpopulation should contain suppressive T cells. Thus, ) were stained with FITC-anti-CD25 (ordinate) and PE-anti-CD45RB (abscissa), PE-anti-CD62L, or PE-anti-CD38 respectively. Among CD25 ϩ cells, CD45RB low or CD45RB high , CD62L low or CD62L high , CD38 high or CD38 low cells (enclosed with rectangles) in the CD25 ϩ population were purified by FACS and stimulated with anti-CD3 antibody as described above. Percentage of each population among enriched CD4 ϩ T cells (~90% purity) is also shown. Each purified population was mixed with CD25 -CD4 ϩ T cells (prepared by FACS as in Fig. 1A ) at an equal ratio and stimulated. A representative result of three independent experiments is shown in (A-D). In these experiments (including those shown in Figs 3-6 below), background counts in the wells with APC only were Ͻ1500 c.p.m. The means of duplicate cultures are shown and the SEMs were all within 10% of the mean.
A blasts from CD25 -CD4 ϩ T cells showed no autoimmuneantigen can prevent autoimmune disease, we transferred to BALB/c nude mice normal CD25 -splenic cells mixed with preventive activity at all. DO11.10 TCR transgenic mice [in which the majority of splenic T cells from DO11.10 transgenic mice and subsequently immunized the nude mice with OVA (Table 2 and CD4 ϩ T cells express TCR specific for an OVA peptide (29) ] harbor CD25 ϩ CD4 ϩ T cells in the thymus and periphery, Fig. 4) . A group of nude mice received the mixture of CD25 -cells and the transgenic T cells that had been activated although their proportion is slightly smaller (~5% of the CD4 ϩ population) than non-transgenic littermates (~10%) (26) . To in vitro with OVA peptides. The inoculated transgenic T cells showed no significant autoimmune-preventive activity in terms determine then whether CD4 ϩ T cells activated by a specific of CD25 ϩ CD4 ϩ T cells in normal naive mice is not significantly affected by T cell activation. (Fig. 1) . To determine then whether any anergic T cells are suppressive to other T cells, we rendered CD25 -CD4 ϩ T cells anergic by treating them in vitro with IM overnight and examined their in vitro suppressive activity on anti-CD3 antibody-stimulated proliferation of freshly prepared CD25 -CD4 ϩ T cells (Fig. 5A) and their in vivo autoimmunesuppressive activity (Fig. 6 and Table 3 , experiment G). Such anergy-induced T cells derived from CD25 -CD4 ϩ T cells failed to suppress the responses of CD25 -CD4 ϩ T cells in vitro or to prevent the development of autoimmune disease in vivo. Exogenously added IL-2 partially restored the response of IM-treated CD25 -CD4 ϩ T cells, exerting no significant effects on their suppressive activity (Fig. 5B) . Furthermore, transfer of IM-treated CD25 -spleen cells to nude mice produced autoimmune diseases at similar incidences and with similar severities as the transfer of non-treated CD25 -spleen cells (Table 3 , experiment D). The results indicate that the anergic state of IM-treated cells may be limited in duration and hardly alter the autoimmune-inducing activity of the CD25 -CD4 ϩ population.
IM-induced anergic T cells are unable to exert suppressive activity
Besides IM treatment, we attempted to induce anergy in purified CD25 -CD4 ϩ T cells (or T cell lines derived from CD25 -CD4 ϩ T cells) by culturing them on anti-CD3 antibodybound plates (38) . The anergy thus induced was, however, transient and incomplete when compared with IM treatment, and not significantly suppressive on the activation/proliferation of CD25 -CD4 ϩ T cells (data not shown). In contrast with the treatment of CD25 ϩ CD4 ϩ T cells with Con (ordinate) and PE-anti-CD25 (abscissa) on day 3 or 7 of culture.
A alone (Fig. 1A) , treatment of CD25 ϩ CD4 ϩ T cells with Con ( Fig. 5B) (25) . Furthermore, BALB/c splenic cells similarly
The cells were stained with FITC-anti-Thy-1.1 or anti-Thy-1.2 and PEtreated with Con A and IL-2 not only failed to prevent anti-CD25 on day 3 or 7 of culture. A representative result of three independent experiments is shown. autoimmune disease in nude mice when co-transferred with CD25 -spleen cells (Table 3 , experiment F); they themselves also produced autoimmune disease in nude mice (Table 3 , experiment C, and Fig. 6 ) (25) . As the controls of these of the incidence of various autoimmune diseases (Table 2) , experiments, spleen cells treated with Con A alone elicited the severity of gastritis and the titers of anti-parietal cell few autoimmune diseases (Table 3 , experiment B), whereas autoantibodies (Fig. 4) , whether the co-transferred transgenic Con A-treated CD25 -spleen cells efficiently produced various CD4 ϩ T cells were activated in vivo or in vitro. By contrast, autoimmune diseases at high incidences (data not shown). CD4 ϩ T cells from non-transgenic littermates efficiently preThus, treatment of normal spleen cells, especially CD4 ϩ vented autoimmune disease.
T cells, with a high dose of IL-2 along with TCR stimulation Thus, the autoimmune-preventive activity is in the can abrogate not only the in vitro suppressive activity but CD25 ϩ CD4 ϩ population present in normal naive mice and polyalso the in vivo autoimmune-preventive activity of clonally activated CD25 -CD4 ϩ T cells or homogenous antigen-CD25 ϩ CD4 ϩ T cells. specific CD4 ϩ transgenic T cells activated by a specific antigen bear no significant autoimmune-preventive activity. The results Discussion indicate that mere activation of CD4 ϩ or CD8 ϩ T cells to CD25 ϩ states is insufficient for conferring on T cells an autoimmune-
The immunoregulatory CD4 ϩ T cells concerned with the maintenance of natural immunologic self-tolerance appear to preventive activity and that the autoimmune-preventive activity Indicated numbers of CD25 -spleen cells were prepared from 2-to 3-month-old female BALB/c nu/ϩ or ϩ/ϩ mice by treatment with anti-CD25 antibody and rabbit complement, and i.v. transferred to 6-week-old female nu/nu mice (group A). Such CD25 -spleen cells were also co-transferred with indicated numbers of CD4 ϩ normal spleen cells (group B), CD4 ϩ or CD8 ϩ Con A blasts prepared from normal spleen cells (Group C), or CD4 ϩ Con A blasts prepared from CD25 -spleen cells (group D). The recipient nude mice were examined 3 months later for histological and/or serological development of autoimmune diseases. See also Fig. 3 for histological grades of gastritis and titers of antiparietal cell autoantibody. Oophoritides were all grade 2 (9). Three mice in group A showed grade 2 thyroiditis; histologically evident thyroiditides in other mice were grade 1 (9).
a Number of mice bearing respective autoimmune diseases is shown with percentage incidence in parentheses. be, at least in part, CD5 high , RT6.1 ϩ , CD45RB low , CD38 ϩ , of the CD25 ϩ CD4 ϩ T cell population could not be further reduced to a smaller subpopulation expressing CD45RB, CD62L ϩ or CD25 ϩ (4-17,25-28). Our previous report showed that the immunoregulatory activity of the CD5 high or CD45RB low CD62L or CD38 at a high or low level. Second, a high proliferative response of the CD25 -CD4 ϩ T cell population, CD4 ϩ T cell population could be attributed to CD25 ϩ T cells included in it (9, 25, 26) . In addition to this finding, the following which contains T cells expressing CD38, CD62L or CD45RB at various levels ( Fig. 1) , indicates that, even if the population results in this report indicate that the expression of CD25 is highly specific, when compared with other molecules, for the should contain any suppressive T cells defined by the expression levels of these cell surface molecules, they may not immunoregulatory CD4 ϩ T cells present in the periphery of normal naive mice. First, the anergic and suppressive property be sufficiently suppressive. Third, as discussed below, with in vivo OVA immunization BALB/c athymic nude mice were transferred with CD25 -spleen cells alone (group A) or after mixing with indicated numbers of CD4 ϩ spleen cells from DO11.10 transgenic mice (groups B-D) or normal mice (group E). These nude mice were i.p. immunized with 1 mg of OVA once a week 4 times (groups C and E) or non-immunized (group B). A group of nude mice received CD25 -spleen cells from normal mice and DO11.10 CD4 ϩ spleen cells stimulated in vitro for 7 days with OVA (group D). These mice were examined 3 months later for histological and/or serological development of autoimmune diseases. See also Fig. 4 for histological grades of gastritis and titers of anti-parietal cell autoantibody. Oophoritides were all grade 2. Thyroiditides were all grade 1.
a Number of mice bearing respective autoimmune diseases is shown with percentage incidence in parentheses. Fig. 4 . Failure of CD4 ϩ T cells from TCR transgenic mice to prevent autoimmune gastritis in co-transfer with CD25 -spleen cells. As shown in Table 2 , BALB/c nude mice were transferred with indicated cell suspensions and then immunized with OVA once a week 4 times or nonimmunized. A group of nude mice was transferred with CD25 -spleen cells mixed with transgenic CD4 ϩ T cells that had been stimulated with OVA in vitro, which were then immunized with OVA as other groups of mice. These nude mice were histologically and serologically examined 3 months later. Solid circles, grade 2 gastritis; shaded circles, grade 1 gastritis; open circles, intact gastric mucosa.
CD25 ϩ CD4 ϩ T cells in normal naive mice are continuously appear to be distinct from the usual activated T cells for the following reasons. First, the development of autoimmune and stably expressing CD25 even in the absence of exogenous T cell stimulation, whereas other T cells lose CD25 when disease was prevented by Con A blasts from uneliminated CD4 ϩ T cells, but not by Con A-activated CD4 T cell blasts the stimulation is abrogated (Fig. 2) .
High expression of CD25 and intermediate to low expression prepared from CD25 -CD4 ϩ T cells. The latter rather produced severe autoimmune diseases when transferred to athymic of CD45RB on the immunoregulatory CD25 ϩ CD4 ϩ T cells (as shown in Fig. 1 ) suggest that they might be in an activated nude mice (data not shown). Second, CD25 ϩ CD4 ϩ T cells that had differentiated in a few months from the CD25 -CD4 ϩ or primed state (39-41). The CD25 ϩ CD4 ϩ T cells present in normal naive mice are indeed CD5 high , CD44 high , CD11a/ T cells inoculated into nude mice hardly suppressed the in vitro activation/proliferation of CD25 -CD4 ϩ T cells prepared CD18 high and CD54 high , as observed with activated, primed or memory T cells in general (9,25,26,39-41) . However, they from the same nude mice, as previously shown (26) . Third, BALB/c athymic nude mice were transferred with CD25 -spleen cells (prepared as described in the legend to Table 1 ) (group A), Con A-stimulated CD4 ϩ spleen cells (group B), CD4 ϩ blasts prepared by treatment of spleen cells with Con A and a high dose of IL-2 (see Methods) (group C) or IM-treated CD25 -spleen cells (group D). CD25 -spleen cells were also transferred after mixing with the T cells thus treated (groups E-G). The nude mice were examined 3 months later for histological and/or serological development of autoimmune diseases. See also Fig. 6 for histological grades of gastritis and titers of anti-parietal cell autoantibody. Oophoritides were all grade 2. Thyroiditides were all grade 1. Table 3 were transferred to BALB/c nude mice, which were histologically and serologically examined 3 months later. Solid circles, grade 2 gastritis; shaded circles, grade 1 gastritis; open circles, intact gastric mucosa.
T cell blasts prepared from TCR-transgenic mice, which are contrasts with usual anergic T cells, which will never revert to an anergic state spontaneously once their anergic state is homogeneous in terms of TCR specificity, failed to prevent autoimmune disease even when stimulated in vivo or preabrogated (42) . Second, the suppression by the CD25 ϩ CD4 ϩ T cells is antigen-nonspecific in the effector phase (i.e. they stimulated in vitro with a specific antigen. The result apparently contrasts with our former finding that DO11.10 transgenic suppress not only T cells with the same antigen specificity but also those with other specificities as well, as shown in mice harbor CD25 ϩ CD4 ϩ T cells, which are anergic and exert potent suppression in vitro upon stimulation with an OVA 25), which is similar to linked suppression (45) . In addition, they suppress the activation/proliferation of CD4 ϩ T cells as peptide (25, 26) . This discrepancy could be attributed in part to a smaller number of OVA-activated CD25 ϩ CD4 ϩ regulatory well as CD8 ϩ T cells (25, 26) . This contrasts with antigenspecific or -restricted suppression by experimentally induced T cells contained in the CD4 ϩ T cell inocula for autoimmune prevention, i.e. the size of the CD25 ϩ CD4 ϩ T cell population anergy (18) (19) (20) . Third, the normal thymus appears to be continuously producing the immunoregulatory CD25 ϩ CD4 ϩ in DO11.10 was about half that of normal mice. In addition, a sizable number of the transgenic CD25 ϩ CD4 ϩ T cells T cells which are already anergic and suppressive in the normal thymus (26) . Although T cell clones or lines can be expressed endogenous TCR α chains in association with transgenic TCR β chains, resulting in altered antigen specifiprepared which are anergic and suppressive in vitro, it remains to be determined whether normal T cells can be cities, hence inefficient activation of CD25 ϩ CD4 ϩ regulatory T cells with OVA (26) . Alternatively, but not exclusively, the somehow converted to anergic and suppressive T cells in the periphery when exposed to self-antigens without codiscrepancy could be due to a possible failure of OVA-specific CD25 ϩ CD4 ϩ regulatory T cells to be efficiently guided to the stimulation in vivo (1, [18] [19] [20] .
In conclusion, the present results indicate that naturally APC expressing specific self-antigen peptides, hence failure of controlling self-reactive T cells there (25) .
anergic and suppressive CD25 ϩ CD4 ϩ T cells present in normal naive mice are distinct from other activated, anergic or Another important characteristic of the immunoregulatory CD25 ϩ CD4 ϩ population is that it is naturally anergic to TCR regulatory T cells in phenotypic and functional characteristics. The phenotype of CD25 ϩ CD4 ϩ immunoregulatory T cells, stimulation (Figs 1 and 5 ) (25) (26) (27) . This raises the question whether any T cells rendered anergic can also be suppressive on the other hand, suggests that they themselves may be continuously stimulated with self-antigens, hence in a CD25 ϩ on the activation/proliferation of other T cells (18) (19) (20) . Indeed, recent studies by others have shown that anergic T cells exert activated state, in the normal internal environment and continuously exerting suppressive control of other T cells (including suppression not via humoral factors including immunoregulatory cytokines, but through cell-cell interactions on APC self-reactive T cells) by raising their activation thresholds (25, 26) . Further characterization of this unique regulatory apparently in a manner similar to naturally anergic and suppressive CD25 ϩ CD4 ϩ T cells (19, 20) . These experiment-T cell population is required to elucidate the mechanism of T cell-mediated dominant immunoregulation and thereby to ally induced anergic T cells are also CD25 ϩ in general (42) (43) (44) . Our present experiments, however, showed that when develop ways for effectively treating or preventing autoimmune disease (9), eliciting tumor immunity (46) or inducing CD25 -CD4 ϩ T cells were experimentally rendered anergic in vitro by IM treatment, they were ineffective in inhibiting tolerance to allo-transplants (9), by manipulating the mechanism. the development of autoimmune disease in vivo and in suppressing the activation/proliferation of other T cells in vitro (Table 3 and Fig. 5 ). This difference between our results and Acknowledgements those of others (18) (19) (20) could be attributed, at least in part, to their use of T cell clones, which may be homogenous not and S. Sakaguchi, manuscript in preparation). This markedly
